News
Saneca Pharma appoints new CEO
Contract development and manufacturing organisation (CDMO) Saneca Pharma has announced the appointment of its new CEO, Richard Král. Richard, who has...
Press Releases
Amgen sets up a FDA Advisory Committee Meeting To Review Potential New Use Of BLINCYTO
Amgen announced that the Oncologic Drugs Advisory Committee of the U.S. FDA will review data supporting the BLINCYTO® (blinatumomab) supplemental Biologics License Application (sBLA)...
Press Releases
AbbVie presents New, Late Breaking Investigational Data at 2018 at AAD Annual meeting
AbbVie a global research and development-based biopharmaceutical company, today announced it will present new, late-breaking data across investigational medicines and HUMIRA® (adalimumab) at the...
News
AbbVie raises dividend and buys $10 billion of shares
AbbVie Inc (ABBV.N) said on Thursday its board had approved a $10 billion stock repurchase program, and the drugmaker also increased its quarterly dividend,...
Press Releases
GSK’S Fluarix Tetra (Influenza Vaccine) for ages six months and older RECEIVES European Approval
GSK announced the expanded indication for Fluarix Tetra (Quadrivalent Influenza Vaccine) has been approved in Europe to include adults and now children from six...
Press Releases
GSK submits landmark IMPACT data to European Medicines Agencies for supporting Trelegy Ellipta
GlaxoSmithKline plc and Innoviva, Inc. announced the submission of the landmark IMPACT data to the European Medicines Agency as part of a type II...
News
FDA approves ODD for selumetinib for treating neurofibromatosis type 1 (NF1): Merck
AstraZeneca and Merck, known as MSD outside the U.S. and Canada, announced that the U.S. FDA has granted Orphan Drug Designation (ODD) for selumetinib,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read